img

Global Tigecycline for Injection Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Tigecycline for Injection Market Insights, Forecast to 2034

Global Tigecycline for Injection market is expected to reach to US$ 56 million in 2024, with a positive growth of %, compared with US$ 53 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Tigecycline for Injection industry is evaluated to reach US$ 81 million in 2029. The CAGR will be 6.4% during 2024 to 2029.
According to the Global Use of Medicines 2024 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2024 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
Report Covers
This report presents an overview of global Tigecycline for Injection market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Tigecycline for Injection market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Pfizer
Sino Biopharmaceutical
Zhejiang Hisun Pharma
Hansoh
Abbott
Natco Pharma
Lyka Labs Limited
Fresenius Kabi
Sandoz
APOTEX
Accord Healthcare
Amneal Pharmaceuticals
Jiangsu Aosaikang Pharmaceutical Co.,Ltd.
Segment by Type
Original Drug
Generic Drug

Segment by Application


Hospital
Clinic
Retail Pharmacy
Other

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Tigecycline for Injection plant distribution, commercial date of Tigecycline for Injection, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Tigecycline for Injection introduction, etc. Tigecycline for Injection Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Tigecycline for Injection
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Tigecycline for Injection Product Introduction
1.2 Market by Type
1.2.1 Global Tigecycline for Injection Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Original Drug
1.2.3 Generic Drug
1.3 Market by Application
1.3.1 Global Tigecycline for Injection Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Retail Pharmacy
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Tigecycline for Injection Sales Estimates and Forecasts 2018-2029
2.2 Global Tigecycline for Injection Revenue by Region
2.2.1 Global Tigecycline for Injection Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Tigecycline for Injection Revenue by Region (2018-2024)
2.2.3 Global Tigecycline for Injection Revenue by Region (2024-2029)
2.2.4 Global Tigecycline for Injection Revenue Market Share by Region (2018-2029)
2.3 Global Tigecycline for Injection Sales Estimates and Forecasts 2018-2029
2.4 Global Tigecycline for Injection Sales by Region
2.4.1 Global Tigecycline for Injection Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Tigecycline for Injection Sales by Region (2018-2024)
2.4.3 Global Tigecycline for Injection Sales by Region (2024-2029)
2.4.4 Global Tigecycline for Injection Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Tigecycline for Injection Sales by Manufacturers
3.1.1 Global Tigecycline for Injection Sales by Manufacturers (2018-2024)
3.1.2 Global Tigecycline for Injection Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Tigecycline for Injection in 2022
3.2 Global Tigecycline for Injection Revenue by Manufacturers
3.2.1 Global Tigecycline for Injection Revenue by Manufacturers (2018-2024)
3.2.2 Global Tigecycline for Injection Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Tigecycline for Injection Revenue in 2022
3.3 Global Key Players of Tigecycline for Injection, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Tigecycline for Injection Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Tigecycline for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Tigecycline for Injection, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Tigecycline for Injection, Product Offered and Application
3.8 Global Key Manufacturers of Tigecycline for Injection, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Tigecycline for Injection Sales by Type
4.1.1 Global Tigecycline for Injection Historical Sales by Type (2018-2024)
4.1.2 Global Tigecycline for Injection Forecasted Sales by Type (2024-2029)
4.1.3 Global Tigecycline for Injection Sales Market Share by Type (2018-2029)
4.2 Global Tigecycline for Injection Revenue by Type
4.2.1 Global Tigecycline for Injection Historical Revenue by Type (2018-2024)
4.2.2 Global Tigecycline for Injection Forecasted Revenue by Type (2024-2029)
4.2.3 Global Tigecycline for Injection Revenue Market Share by Type (2018-2029)
4.3 Global Tigecycline for Injection Price by Type
4.3.1 Global Tigecycline for Injection Price by Type (2018-2024)
4.3.2 Global Tigecycline for Injection Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Tigecycline for Injection Sales by Application
5.1.1 Global Tigecycline for Injection Historical Sales by Application (2018-2024)
5.1.2 Global Tigecycline for Injection Forecasted Sales by Application (2024-2029)
5.1.3 Global Tigecycline for Injection Sales Market Share by Application (2018-2029)
5.2 Global Tigecycline for Injection Revenue by Application
5.2.1 Global Tigecycline for Injection Historical Revenue by Application (2018-2024)
5.2.2 Global Tigecycline for Injection Forecasted Revenue by Application (2024-2029)
5.2.3 Global Tigecycline for Injection Revenue Market Share by Application (2018-2029)
5.3 Global Tigecycline for Injection Price by Application
5.3.1 Global Tigecycline for Injection Price by Application (2018-2024)
5.3.2 Global Tigecycline for Injection Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Tigecycline for Injection Market Size by Type
6.1.1 US & Canada Tigecycline for Injection Sales by Type (2018-2029)
6.1.2 US & Canada Tigecycline for Injection Revenue by Type (2018-2029)
6.2 US & Canada Tigecycline for Injection Market Size by Application
6.2.1 US & Canada Tigecycline for Injection Sales by Application (2018-2029)
6.2.2 US & Canada Tigecycline for Injection Revenue by Application (2018-2029)
6.3 US & Canada Tigecycline for Injection Market Size by Country
6.3.1 US & Canada Tigecycline for Injection Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Tigecycline for Injection Sales by Country (2018-2029)
6.3.3 US & Canada Tigecycline for Injection Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Tigecycline for Injection Market Size by Type
7.1.1 Europe Tigecycline for Injection Sales by Type (2018-2029)
7.1.2 Europe Tigecycline for Injection Revenue by Type (2018-2029)
7.2 Europe Tigecycline for Injection Market Size by Application
7.2.1 Europe Tigecycline for Injection Sales by Application (2018-2029)
7.2.2 Europe Tigecycline for Injection Revenue by Application (2018-2029)
7.3 Europe Tigecycline for Injection Market Size by Country
7.3.1 Europe Tigecycline for Injection Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Tigecycline for Injection Sales by Country (2018-2029)
7.3.3 Europe Tigecycline for Injection Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Tigecycline for Injection Market Size
8.1.1 China Tigecycline for Injection Sales (2018-2029)
8.1.2 China Tigecycline for Injection Revenue (2018-2029)
8.2 China Tigecycline for Injection Market Size by Application
8.2.1 China Tigecycline for Injection Sales by Application (2018-2029)
8.2.2 China Tigecycline for Injection Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Tigecycline for Injection Market Size by Type
9.1.1 Asia Tigecycline for Injection Sales by Type (2018-2029)
9.1.2 Asia Tigecycline for Injection Revenue by Type (2018-2029)
9.2 Asia Tigecycline for Injection Market Size by Application
9.2.1 Asia Tigecycline for Injection Sales by Application (2018-2029)
9.2.2 Asia Tigecycline for Injection Revenue by Application (2018-2029)
9.3 Asia Tigecycline for Injection Sales by Region
9.3.1 Asia Tigecycline for Injection Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Tigecycline for Injection Revenue by Region (2018-2029)
9.3.3 Asia Tigecycline for Injection Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Tigecycline for Injection Market Size by Type
10.1.1 Middle East, Africa and Latin America Tigecycline for Injection Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Tigecycline for Injection Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Tigecycline for Injection Market Size by Application
10.2.1 Middle East, Africa and Latin America Tigecycline for Injection Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Tigecycline for Injection Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Tigecycline for Injection Sales by Country
10.3.1 Middle East, Africa and Latin America Tigecycline for Injection Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Tigecycline for Injection Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Tigecycline for Injection Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Tigecycline for Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Pfizer Tigecycline for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 Sino Biopharmaceutical
11.2.1 Sino Biopharmaceutical Company Information
11.2.2 Sino Biopharmaceutical Overview
11.2.3 Sino Biopharmaceutical Tigecycline for Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Sino Biopharmaceutical Tigecycline for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sino Biopharmaceutical Recent Developments
11.3 Zhejiang Hisun Pharma
11.3.1 Zhejiang Hisun Pharma Company Information
11.3.2 Zhejiang Hisun Pharma Overview
11.3.3 Zhejiang Hisun Pharma Tigecycline for Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Zhejiang Hisun Pharma Tigecycline for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Zhejiang Hisun Pharma Recent Developments
11.4 Hansoh
11.4.1 Hansoh Company Information
11.4.2 Hansoh Overview
11.4.3 Hansoh Tigecycline for Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Hansoh Tigecycline for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Hansoh Recent Developments
11.5 Abbott
11.5.1 Abbott Company Information
11.5.2 Abbott Overview
11.5.3 Abbott Tigecycline for Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Abbott Tigecycline for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Abbott Recent Developments
11.6 Natco Pharma
11.6.1 Natco Pharma Company Information
11.6.2 Natco Pharma Overview
11.6.3 Natco Pharma Tigecycline for Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Natco Pharma Tigecycline for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Natco Pharma Recent Developments
11.7 Lyka Labs Limited
11.7.1 Lyka Labs Limited Company Information
11.7.2 Lyka Labs Limited Overview
11.7.3 Lyka Labs Limited Tigecycline for Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Lyka Labs Limited Tigecycline for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Lyka Labs Limited Recent Developments
11.8 Fresenius Kabi
11.8.1 Fresenius Kabi Company Information
11.8.2 Fresenius Kabi Overview
11.8.3 Fresenius Kabi Tigecycline for Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Fresenius Kabi Tigecycline for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Fresenius Kabi Recent Developments
11.9 Sandoz
11.9.1 Sandoz Company Information
11.9.2 Sandoz Overview
11.9.3 Sandoz Tigecycline for Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Sandoz Tigecycline for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Sandoz Recent Developments
11.10 APOTEX
11.10.1 APOTEX Company Information
11.10.2 APOTEX Overview
11.10.3 APOTEX Tigecycline for Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 APOTEX Tigecycline for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 APOTEX Recent Developments
11.11 Accord Healthcare
11.11.1 Accord Healthcare Company Information
11.11.2 Accord Healthcare Overview
11.11.3 Accord Healthcare Tigecycline for Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Accord Healthcare Tigecycline for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Accord Healthcare Recent Developments
11.12 Amneal Pharmaceuticals
11.12.1 Amneal Pharmaceuticals Company Information
11.12.2 Amneal Pharmaceuticals Overview
11.12.3 Amneal Pharmaceuticals Tigecycline for Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Amneal Pharmaceuticals Tigecycline for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Amneal Pharmaceuticals Recent Developments
11.13 Jiangsu Aosaikang Pharmaceutical Co.,Ltd.
11.13.1 Jiangsu Aosaikang Pharmaceutical Co.,Ltd. Company Information
11.13.2 Jiangsu Aosaikang Pharmaceutical Co.,Ltd. Overview
11.13.3 Jiangsu Aosaikang Pharmaceutical Co.,Ltd. Tigecycline for Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Jiangsu Aosaikang Pharmaceutical Co.,Ltd. Tigecycline for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Jiangsu Aosaikang Pharmaceutical Co.,Ltd. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Tigecycline for Injection Industry Chain Analysis
12.2 Tigecycline for Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Tigecycline for Injection Production Mode & Process
12.4 Tigecycline for Injection Sales and Marketing
12.4.1 Tigecycline for Injection Sales Channels
12.4.2 Tigecycline for Injection Distributors
12.5 Tigecycline for Injection Customers
13 Market Dynamics
13.1 Tigecycline for Injection Industry Trends
13.2 Tigecycline for Injection Market Drivers
13.3 Tigecycline for Injection Market Challenges
13.4 Tigecycline for Injection Market Restraints
14 Key Findings in The Global Tigecycline for Injection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Tigecycline for Injection Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Original Drug
Table 3. Major Manufacturers of Generic Drug
Table 4. Global Tigecycline for Injection Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Tigecycline for Injection Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Tigecycline for Injection Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Tigecycline for Injection Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Tigecycline for Injection Revenue Market Share by Region (2018-2024)
Table 9. Global Tigecycline for Injection Revenue Market Share by Region (2024-2029)
Table 10. Global Tigecycline for Injection Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Tigecycline for Injection Sales by Region (2018-2024) & (K Units)
Table 12. Global Tigecycline for Injection Sales by Region (2024-2029) & (K Units)
Table 13. Global Tigecycline for Injection Sales Market Share by Region (2018-2024)
Table 14. Global Tigecycline for Injection Sales Market Share by Region (2024-2029)
Table 15. Global Tigecycline for Injection Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Tigecycline for Injection Sales Share by Manufacturers (2018-2024)
Table 17. Global Tigecycline for Injection Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Tigecycline for Injection Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Tigecycline for Injection, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Tigecycline for Injection Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global Tigecycline for Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Tigecycline for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tigecycline for Injection as of 2022)
Table 23. Global Key Manufacturers of Tigecycline for Injection, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Tigecycline for Injection, Product Offered and Application
Table 25. Global Key Manufacturers of Tigecycline for Injection, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Tigecycline for Injection Sales by Type (2018-2024) & (K Units)
Table 28. Global Tigecycline for Injection Sales by Type (2024-2029) & (K Units)
Table 29. Global Tigecycline for Injection Sales Share by Type (2018-2024)
Table 30. Global Tigecycline for Injection Sales Share by Type (2024-2029)
Table 31. Global Tigecycline for Injection Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Tigecycline for Injection Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Tigecycline for Injection Revenue Share by Type (2018-2024)
Table 34. Global Tigecycline for Injection Revenue Share by Type (2024-2029)
Table 35. Tigecycline for Injection Price by Type (2018-2024) & (US$/Unit)
Table 36. Global Tigecycline for Injection Price Forecast by Type (2024-2029) & (US$/Unit)
Table 37. Global Tigecycline for Injection Sales by Application (2018-2024) & (K Units)
Table 38. Global Tigecycline for Injection Sales by Application (2024-2029) & (K Units)
Table 39. Global Tigecycline for Injection Sales Share by Application (2018-2024)
Table 40. Global Tigecycline for Injection Sales Share by Application (2024-2029)
Table 41. Global Tigecycline for Injection Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Tigecycline for Injection Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Tigecycline for Injection Revenue Share by Application (2018-2024)
Table 44. Global Tigecycline for Injection Revenue Share by Application (2024-2029)
Table 45. Tigecycline for Injection Price by Application (2018-2024) & (US$/Unit)
Table 46. Global Tigecycline for Injection Price Forecast by Application (2024-2029) & (US$/Unit)
Table 47. US & Canada Tigecycline for Injection Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Tigecycline for Injection Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Tigecycline for Injection Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Tigecycline for Injection Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Tigecycline for Injection Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Tigecycline for Injection Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Tigecycline for Injection Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Tigecycline for Injection Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Tigecycline for Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Tigecycline for Injection Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Tigecycline for Injection Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Tigecycline for Injection Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Tigecycline for Injection Sales by Country (2024-2029) & (K Units)
Table 60. Europe Tigecycline for Injection Sales by Type (2018-2024) & (K Units)
Table 61. Europe Tigecycline for Injection Sales by Type (2024-2029) & (K Units)
Table 62. Europe Tigecycline for Injection Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Tigecycline for Injection Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Tigecycline for Injection Sales by Application (2018-2024) & (K Units)
Table 65. Europe Tigecycline for Injection Sales by Application (2024-2029) & (K Units)
Table 66. Europe Tigecycline for Injection Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Tigecycline for Injection Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Tigecycline for Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Tigecycline for Injection Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Tigecycline for Injection Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Tigecycline for Injection Sales by Country (2018-2024) & (K Units)
Table 72. Europe Tigecycline for Injection Sales by Country (2024-2029) & (K Units)
Table 73. China Tigecycline for Injection Sales by Type (2018-2024) & (K Units)
Table 74. China Tigecycline for Injection Sales by Type (2024-2029) & (K Units)
Table 75. China Tigecycline for Injection Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Tigecycline for Injection Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Tigecycline for Injection Sales by Application (2018-2024) & (K Units)
Table 78. China Tigecycline for Injection Sales by Application (2024-2029) & (K Units)
Table 79. China Tigecycline for Injection Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Tigecycline for Injection Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Tigecycline for Injection Sales by Type (2018-2024) & (K Units)
Table 82. Asia Tigecycline for Injection Sales by Type (2024-2029) & (K Units)
Table 83. Asia Tigecycline for Injection Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Tigecycline for Injection Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Tigecycline for Injection Sales by Application (2018-2024) & (K Units)
Table 86. Asia Tigecycline for Injection Sales by Application (2024-2029) & (K Units)
Table 87. Asia Tigecycline for Injection Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Tigecycline for Injection Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Tigecycline for Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Tigecycline for Injection Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Tigecycline for Injection Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Tigecycline for Injection Sales by Region (2018-2024) & (K Units)
Table 93. Asia Tigecycline for Injection Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Tigecycline for Injection Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Tigecycline for Injection Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Tigecycline for Injection Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Tigecycline for Injection Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Tigecycline for Injection Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Tigecycline for Injection Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Tigecycline for Injection Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Tigecycline for Injection Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Tigecycline for Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Tigecycline for Injection Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Tigecycline for Injection Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Tigecycline for Injection Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Tigecycline for Injection Sales by Country (2024-2029) & (K Units)
Table 107. Pfizer Company Information
Table 108. Pfizer Description and Major Businesses
Table 109. Pfizer Tigecycline for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Pfizer Tigecycline for Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Pfizer Recent Developments
Table 112. Sino Biopharmaceutical Company Information
Table 113. Sino Biopharmaceutical Description and Major Businesses
Table 114. Sino Biopharmaceutical Tigecycline for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Sino Biopharmaceutical Tigecycline for Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Sino Biopharmaceutical Recent Developments
Table 117. Zhejiang Hisun Pharma Company Information
Table 118. Zhejiang Hisun Pharma Description and Major Businesses
Table 119. Zhejiang Hisun Pharma Tigecycline for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Zhejiang Hisun Pharma Tigecycline for Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Zhejiang Hisun Pharma Recent Developments
Table 122. Hansoh Company Information
Table 123. Hansoh Description and Major Businesses
Table 124. Hansoh Tigecycline for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Hansoh Tigecycline for Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Hansoh Recent Developments
Table 127. Abbott Company Information
Table 128. Abbott Description and Major Businesses
Table 129. Abbott Tigecycline for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Abbott Tigecycline for Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Abbott Recent Developments
Table 132. Natco Pharma Company Information
Table 133. Natco Pharma Description and Major Businesses
Table 134. Natco Pharma Tigecycline for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. Natco Pharma Tigecycline for Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Natco Pharma Recent Developments
Table 137. Lyka Labs Limited Company Information
Table 138. Lyka Labs Limited Description and Major Businesses
Table 139. Lyka Labs Limited Tigecycline for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. Lyka Labs Limited Tigecycline for Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Lyka Labs Limited Recent Developments
Table 142. Fresenius Kabi Company Information
Table 143. Fresenius Kabi Description and Major Businesses
Table 144. Fresenius Kabi Tigecycline for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Fresenius Kabi Tigecycline for Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Fresenius Kabi Recent Developments
Table 147. Sandoz Company Information
Table 148. Sandoz Description and Major Businesses
Table 149. Sandoz Tigecycline for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. Sandoz Tigecycline for Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Sandoz Recent Developments
Table 152. APOTEX Company Information
Table 153. APOTEX Description and Major Businesses
Table 154. APOTEX Tigecycline for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. APOTEX Tigecycline for Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. APOTEX Recent Developments
Table 157. Accord Healthcare Company Information
Table 158. Accord Healthcare Description and Major Businesses
Table 159. Accord Healthcare Tigecycline for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. Accord Healthcare Tigecycline for Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Accord Healthcare Recent Developments
Table 162. Amneal Pharmaceuticals Company Information
Table 163. Amneal Pharmaceuticals Description and Major Businesses
Table 164. Amneal Pharmaceuticals Tigecycline for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 165. Amneal Pharmaceuticals Tigecycline for Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Amneal Pharmaceuticals Recent Developments
Table 167. Jiangsu Aosaikang Pharmaceutical Co.,Ltd. Company Information
Table 168. Jiangsu Aosaikang Pharmaceutical Co.,Ltd. Description and Major Businesses
Table 169. Jiangsu Aosaikang Pharmaceutical Co.,Ltd. Tigecycline for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 170. Jiangsu Aosaikang Pharmaceutical Co.,Ltd. Tigecycline for Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Jiangsu Aosaikang Pharmaceutical Co.,Ltd. Recent Developments
Table 172. Key Raw Materials Lists
Table 173. Raw Materials Key Suppliers Lists
Table 174. Tigecycline for Injection Distributors List
Table 175. Tigecycline for Injection Customers List
Table 176. Tigecycline for Injection Market Trends
Table 177. Tigecycline for Injection Market Drivers
Table 178. Tigecycline for Injection Market Challenges
Table 179. Tigecycline for Injection Market Restraints
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources
List of Figures
Figure 1. Tigecycline for Injection Product Picture
Figure 2. Global Tigecycline for Injection Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Tigecycline for Injection Market Share by Type in 2022 & 2029
Figure 4. Original Drug Product Picture
Figure 5. Generic Drug Product Picture
Figure 6. Global Tigecycline for Injection Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Tigecycline for Injection Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Retail Pharmacy
Figure 11. Other
Figure 12. Tigecycline for Injection Report Years Considered
Figure 13. Global Tigecycline for Injection Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Tigecycline for Injection Revenue 2018-2029 (US$ Million)
Figure 15. Global Tigecycline for Injection Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 16. Global Tigecycline for Injection Revenue Market Share by Region (2018-2029)
Figure 17. Global Tigecycline for Injection Sales 2018-2029 ((K Units)
Figure 18. Global Tigecycline for Injection Sales Market Share by Region (2018-2029)
Figure 19. US & Canada Tigecycline for Injection Sales YoY (2018-2029) & (K Units)
Figure 20. US & Canada Tigecycline for Injection Revenue YoY (2018-2029) & (US$ Million)
Figure 21. Europe Tigecycline for Injection Sales YoY (2018-2029) & (K Units)
Figure 22. Europe Tigecycline for Injection Revenue YoY (2018-2029) & (US$ Million)
Figure 23. China Tigecycline for Injection Sales YoY (2018-2029) & (K Units)
Figure 24. China Tigecycline for Injection Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Asia (excluding China) Tigecycline for Injection Sales YoY (2018-2029) & (K Units)
Figure 26. Asia (excluding China) Tigecycline for Injection Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Tigecycline for Injection Sales YoY (2018-2029) & (K Units)
Figure 28. Middle East, Africa and Latin America Tigecycline for Injection Revenue YoY (2018-2029) & (US$ Million)
Figure 29. The Tigecycline for Injection Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 30. The Top 5 and 10 Largest Manufacturers of Tigecycline for Injection in the World: Market Share by Tigecycline for Injection Revenue in 2022
Figure 31. Global Tigecycline for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Tigecycline for Injection Sales Market Share by Type (2018-2029)
Figure 33. Global Tigecycline for Injection Revenue Market Share by Type (2018-2029)
Figure 34. Global Tigecycline for Injection Sales Market Share by Application (2018-2029)
Figure 35. Global Tigecycline for Injection Revenue Market Share by Application (2018-2029)
Figure 36. US & Canada Tigecycline for Injection Sales Market Share by Type (2018-2029)
Figure 37. US & Canada Tigecycline for Injection Revenue Market Share by Type (2018-2029)
Figure 38. US & Canada Tigecycline for Injection Sales Market Share by Application (2018-2029)
Figure 39. US & Canada Tigecycline for Injection Revenue Market Share by Application (2018-2029)
Figure 40. US & Canada Tigecycline for Injection Revenue Share by Country (2018-2029)
Figure 41. US & Canada Tigecycline for Injection Sales Share by Country (2018-2029)
Figure 42. U.S. Tigecycline for Injection Revenue (2018-2029) & (US$ Million)
Figure 43. Canada Tigecycline for Injection Revenue (2018-2029) & (US$ Million)
Figure 44. Europe Tigecycline for Injection Sales Market Share by Type (2018-2029)
Figure 45. Europe Tigecycline for Injection Revenue Market Share by Type (2018-2029)
Figure 46. Europe Tigecycline for Injection Sales Market Share by Application (2018-2029)
Figure 47. Europe Tigecycline for Injection Revenue Market Share by Application (2018-2029)
Figure 48. Europe Tigecycline for Injection Revenue Share by Country (2018-2029)
Figure 49. Europe Tigecycline for Injection Sales Share by Country (2018-2029)
Figure 50. Germany Tigecycline for Injection Revenue (2018-2029) & (US$ Million)
Figure 51. France Tigecycline for Injection Revenue (2018-2029) & (US$ Million)
Figure 52. U.K. Tigecycline for Injection Revenue (2018-2029) & (US$ Million)
Figure 53. Italy Tigecycline for Injection Revenue (2018-2029) & (US$ Million)
Figure 54. Russia Tigecycline for Injection Revenue (2018-2029) & (US$ Million)
Figure 55. China Tigecycline for Injection Sales Market Share by Type (2018-2029)
Figure 56. China Tigecycline for Injection Revenue Market Share by Type (2018-2029)
Figure 57. China Tigecycline for Injection Sales Market Share by Application (2018-2029)
Figure 58. China Tigecycline for Injection Revenue Market Share by Application (2018-2029)
Figure 59. Asia Tigecycline for Injection Sales Market Share by Type (2018-2029)
Figure 60. Asia Tigecycline for Injection Revenue Market Share by Type (2018-2029)
Figure 61. Asia Tigecycline for Injection Sales Market Share by Application (2018-2029)
Figure 62. Asia Tigecycline for Injection Revenue Market Share by Application (2018-2029)
Figure 63. Asia Tigecycline for Injection Revenue Share by Region (2018-2029)
Figure 64. Asia Tigecycline for Injection Sales Share by Region (2018-2029)
Figure 65. Japan Tigecycline for Injection Revenue (2018-2029) & (US$ Million)
Figure 66. South Korea Tigecycline for Injection Revenue (2018-2029) & (US$ Million)
Figure 67. China Taiwan Tigecycline for Injection Revenue (2018-2029) & (US$ Million)
Figure 68. Southeast Asia Tigecycline for Injection Revenue (2018-2029) & (US$ Million)
Figure 69. India Tigecycline for Injection Revenue (2018-2029) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Tigecycline for Injection Sales Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Tigecycline for Injection Revenue Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Tigecycline for Injection Sales Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Tigecycline for Injection Revenue Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Tigecycline for Injection Revenue Share by Country (2018-2029)
Figure 75. Middle East, Africa and Latin America Tigecycline for Injection Sales Share by Country (2018-2029)
Figure 76. Brazil Tigecycline for Injection Revenue (2018-2029) & (US$ Million)
Figure 77. Mexico Tigecycline for Injection Revenue (2018-2029) & (US$ Million)
Figure 78. Turkey Tigecycline for Injection Revenue (2018-2029) & (US$ Million)
Figure 79. Israel Tigecycline for Injection Revenue (2018-2029) & (US$ Million)
Figure 80. GCC Countries Tigecycline for Injection Revenue (2018-2029) & (US$ Million)
Figure 81. Tigecycline for Injection Value Chain
Figure 82. Tigecycline for Injection Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed